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neuro-interventional procedures. Methods: Radiation dose received at left outer canthus (LOC) and left 
eyelid (LE) were measured using Metal-Oxide-Semiconductor Field-Effect Transistor dosimeters on 35 pa- 
tients who underwent diagnostic or cerebral embolization procedures. Results: The radiation dose 
received at the LOC region was significantly higher than the dose received by the LE. The maximum eye 
lens dose of 1492 mGy was measured at LOC region for an AVM case, followed by 907 mGy for an 
aneurysm case and 665 mGy for a diagnostic angiography procedure. Strong correlations (shown as R2) 
were observed between kerma-area-product and measured eye doses (LOC:0.78, LE: 0.68). Lateral and 
frontal air-kerma showed strong correlations with measured dose at LOC (AKL:0.93, AKF:0.78) and a 
weak correlation with measured dose at LE. A moderate correlation was observed between fluoroscopic 
time and dose measured at LE and LOC regions. Conclusions: The MO Skin dose-monitoring system 
represents a new tool enabling real-time monitoring of eye lens dose during neuro-interventional 
procedures. This system can provide interventionalists with information needed to adjust the clinical 
procedure to control the patient’s dose. Key Points • Real-time patient dose monitoring helps 
interventionalists to monitor doses. • Strong correlation was observed between kerma-area-product and 
measured eye doses. • Radiation dose at left outer canthus was higher than at left eyelid 
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Abstract Objectives: The purpose of this study was to develop a real-time 
dose monitoring system to measure the patient’s eye lens dose during neuro-
interventional procedures. Methods: Radiation dose received at left outer 
canthus (LOC) and left eyelid (LE) were measured using Metal-Oxide-
Semiconductor Field-Effect Transistor dosimeters on 35 patients who 
underwent diagnostic or cerebral embolization procedures. Results: The 
radiation dose received at the LOC region was significantly higher than the 
dose received by the LE. The maximum eye lens dose of 1492 mGy was 
measured at LOC region for an AVM case, followed by 907 mGy for an 
aneurysm case and 665 mGy for a diagnostic angiography procedure. Strong 
correlations were observed between kerma-area-product and measured eye 
doses (LOC: 0.78, LE: 0.68). Lateral and frontal air-kerma showed strong 
correlations with measured dose at LOC (AKL: 0.93, AKF: 0.78) and weak 
correlation with measured dose at LE. A moderate correlation was observed 
between fluoroscopic time and dose measured at LE and LOC regions. 
Conclusions: The MOSkin dose monitoring system represents a new tool 
enabling real-time monitoring of patient’s eye lens dose during neuro-
interventional procedures. This system can provide interventionalists with 
information needed to adjust the clinical procedure to control the patient’s 
dose.  
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Key point: 
1. Real-time patient dose monitoring helps interventionalists to monitor 
patient’s dose. 
2. Strong correlation was observed between kerma-area-product and 
measured patients’ eye doses 
3. Radiation dose at patients’ left outer canthus was higher than left eyelid  
 
 
Abbreviation list: 
1. FT= Fluoroscopic time  
2. KAP= Kerma-area-product 
3. AK= Air kerma 
4. IRP= Interventional reference point  
5. LE= Left eyelid  
6. LOC= Left outer canthus  
7. MOSFET= Metal-Oxide-Semiconductor Field-Effect Transistor 
 4 
I. Introduction 
Fluoroscopy-guided interventional radiological procedures provide enormous 
advantages over invasive surgical procedures. However, long radiation 
exposure during complicated interventional radiology (IR) procedures remains 
a concern. Skin injuries are the most frequently encountered tissue reaction 
effects from IR procedures [1-4]. Different indirect dose evaluation techniques, 
such as fluoroscopic time (FT), kerma-area-product (KAP), dose level at the 
interventional reference point (IRP), and peak skin dose, have been established 
as skin dose indicators for IR procedures [5, 6]. Other than skin dose, the 
radiation dose to patient’s eye lens is also a concern, particularly for patients 
undergoing long neuro-interventional procedures. Cataract formations are late 
effects of radiation exposure.  Unlike skin reactions, which are visible after 
about 2 weeks, they usually appear after 10-20 years. To date, different 
threshold doses have been proposed for cataract formation during acute 
radiation exposure. The International Commission on Radiological Protection 
(ICRP) [7], following recent epidemiology studies [8-11], issued a new 
statement in 2011 on the threshold of 0.5 Gy in absorbed dose to eye lens. 
Currently, different direct dosimeters have been used as post-processing dose 
evaluation methods to evaluate the patient’s skin dose and eye lens dose during 
IR procedures [12-17]. To the best of the authors’ knowledge, there is no real-
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time in vivo dosimetry system that has been used for patient dose monitoring 
during IR procedures.  
The purpose of the present study was to: first, demonstrate a new real-time 
dose monitoring system for determining patient eye lens dose during neuro-
interventional procedures; and second, to evaluate correlations of the patient 
eye lens dose with dose metric parameters, like KAP, FT, and AK of the 
frontal (AKF) and lateral tube (AKL). In this study, our hypothesis was that not 
all existing dose metric parameters are suitable to indicate patient’s eye lens 
dose.  
 
II. Materials and Methods 
II. A. Patients  
The real-time monitoring of eye lens dose was carried out on 35 patients, 24 
female patients (45 ±16.9 years) and 11 male patients (age 46 ±16.8 years), 
comprising 19 diagnostic angiographies, 8 treatments of cerebral aneurysms, 
and 8 embolizations of AVMs. The same interventionalist and radiography 
team performed the neuro-interventional procedures from March 2013 to 
March 2014.   
II. B. X-ray equipment  
The neuro-interventional procedures were performed using an Allura Xper 
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FD20/20
®
 biplane system (Philips Healthcare, Best, The Netherlands) at the 
University of Malaya Medical Centre (UMMC). This suite consists of one 
ceiling-mounted x-ray tube and one floor-mounted x-ray tube (C-arm) 
equipped with a 30 cm x 38 cm dynamic flat detector. This machine is 
equipped with different electronic rectangular field-of-views (FOVs), which 
change the sensitive image detector area from 15 cm to 48 cm while the 
exposure tube potential varies between 40 and 125 kVp. This machine can 
generate five frame rate ranges for vascular procedures (0.5fps, 2fps, 3fps, 
4fps, and 6fps) and two frame rate ranges for cardiac procedures (15fps and 
30fps). The tube voltage is controlled by an automatic brightness control 
system (ABC). The Allura Xper FD20/20 machine can apply different 
filtrations, 0.2 mm, 0.5, and 1.0 mm copper equivalent, which are specified to 
different types of exposures.  
II. C. MOSkin Dosimetry system and measurement setup 
MOSkin detector is a new type of Metal Oxide Semiconductor Field Effect 
Transistor (MOSFET) detector designed by the Centre for Medical Radiation 
Physics (CMRP), University of Wollongong, Australia. This detector was 
specially designed for skin dose measurement and has previously been used for 
patient skin dose measurement during radiotherapy procedures [18-22]. 
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This detector is composed of a hermitically sealed MOSFET detector in a 
kapton strip using “drop-in” packaging technology [18]. A layer of polyamide 
film protects and encapsulates the radiosensitive MOSFET sensor, as well as 
provides a reproducible build-up layer with water equivalent depth of 0.07 mm 
[Figure 1]. The principle of operation of the MOSkin detector is based on the 
change of the threshold voltage (∆Vth), which is proportional to the irradiation 
dose [19, ("Characterization of MOSkin detector for in vivo skin dose 
measurement during interventional radiology procedures" by Safari MJ, Wong 
JHD, Ng KH et al, submitted in September 2014, Medical Physics Journal)]. 
The MOSkin detector was characterized under Radiation Qualities in Radiation 
beams emerging from the x-ray tube assembly (RQR) standard beam. This 
detector proved to be reliable when exposed to different dose rates (±3%), 
frame rates (±3%), radiation incident angles (±5%), and exposure energies 
( ±5% ) ("Characterization of MOSkin detector for in vivo skin dose 
measurement during interventional radiology procedures" by Safari MJ, Wong 
JHD, Ng KH et al, submitted in September 2014, Medical Physics Journal). 
The MOSkin detector response (∆Vth) can be recorded either manually from the 
reader or automatically via computer software. In this study, a graphic user 
interface, FETch, was designed to present the dose values in a more visual 
form. This interface displays the accumulated dose in column bar charts and 
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numeric form [Figure 2 (b)]. Dose measurements can be performed at user-
defined readout frequencies (maximum temporal frequency is 1 Hz). With this 
interface, the operators are able to monitor the radiation dose received by the 
patient in a more intuitive and direct manner, providing valuable information 
with minimal or no distraction to the interventionalist during a clinical 
procedure.  
II. B. Data acquisition 
For all the neuro-interventional procedures, the lateral x-ray tube was 
positioned on the left side of the patients’ heads throughout the treatments. A 
study of the exposure parameters during 53 neuro-interventional procedures 
showed that, in 73.7% of the projection times, the frontal tube projections were 
acquired in the posterior-anterior direction (10º RAO-10º LAO) and in 93% of 
the time the lateral tube direction was changed from 70º RAO to 90º RAO. 
("An investigation of the contribution of routine radiological exposure 
parameters to patient’s dose during neuro-interventional radiology procedures: 
A phantom study" by Safari MJ, Wong JHD, Jong WL et al, submitted in 
March 2015, European Radiology). Therefore, the lenses of the left eyes were 
constantly exposed to the primary x-ray beam from the lateral x-ray tube. The 
difference between the radiation doses received in the left and right eyes during 
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cerebral angiography procedures were studied in a pilot study on two patients, 
which revealed that the radiation dose delivered to the left eye region is 
significantly higher (~5 times) than the dose delivered to the right eye. For this 
reason, in this study we focused on the measurement of the dose delivered to 
patients’ left eye. The study of the patients’ eye lens dose was implemented 
using MOSkin detectors. The patients were asked to keep their eyes closed 
during the treatment procedure. Two MOSkin detectors were positioned on the 
patient’s left outer canthus (LOC) and left eyelid (LE) [Figure 3(a)]. This 
detector is not visible on the displayed image and does not interfere with the 
treatment procedure [Figure 3(b)]. The MOSkin detectors were placed on the 
patient’s body for at least 5 minutes to allow the detectors to equilibrate with 
the patient’s body temperature before commencing the measurement. The 
MOSkin dosimetry system equipped with acquisition laptop using FETch 
software was placed in front of the interventionalist and the radiographer 
during the treatment procedures [Figure 2(a)]. Exposure parameters were 
recorded from the console. Measured doses were compared with exposure 
parameters such as FT, KAP, AKF and AKL. 
II. C. Statistical analysis 
Regression correlation tests were carried out to determine the relationships 
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between the MOSkin response and total fluoroscopic time, KAP, AKL as well 
as AKF. All analyses were carried out using SPSS (version 16, SPSS, Chicago, 
IL).  
III. Results 
II. A. Patient’s eye lens dose 
 The average dose received at the outer canthus and eyelid regions showed that 
the radiation dose received at the outer canthus region was significantly higher 
than the dose received at the eyelid region [Table 1]. The range of the AK for 
each tube and, consequently, KAP for AVM procedures, was higher than for 
other procedures. Due to higher dose delivery in AVM procedures, patients 
received higher dose at the outer canthus and eyelid locations [Table 1 and 
Figure 4]. 
Figure 5 shows the correlation between the exposure parameters and received 
dose at LE and LOC.  There is a strong correlation between accumulative KAP 
and dose values at LE and LOC regions (LOC: R
2
=0.78 and LE: R
2
=0.68) 
[Figure 5 (a)]. Moderate correlations were observed between total fluoroscopic 
time and dose at LE and LOC (LOC: R
2
=0.52 and LE: R
2
=0.40) [Figure 5 (b)].  
The accumulative AK for lateral and frontal tubes shows a strong correlation 
with measured dose at LOC (AKL: 0.93 and AKF: 0.78) [Figure 5 (c, d)] but a 
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weak correlation with measured dose at LE (AKL: 0.28 and AKF: 0.10) [Figure 
5 (c, d)]. 
 
II. B. Study of exposure parameters 
Figure 6 shows the accumulated dose trend at LOC for a particular AVM case, 
highlighting the unique capability of the MOSkin dosimetry system. Using the 
MOSkin detector, we can study the trend of the patient’s accumulated dose 
during an interventional procedure. By matching the MOSkin detector response 
and exposure time from the console, we can correlate the dose measured by the 
MOSkin detectors with the machine exposure parameters, thereby 
understanding their contribution to the patient’s received dose. The system not 
only enables us to record real-time patient dose, but also enables us to 
investigate the contribution of each exposure to patient’s dose in terms of 
exposure parameters (kV, mAs, exposure angulation and rotation and number 
of frames) [Figure 6] or exposure types (Fluoroscopy, DSA, cine and road 
mapping) [Figure 7]. From Figure 6, it was found that the sharp increments in 
the detector threshold voltage were due to high dose rate DSA acquisition 
technique. For this particular AVM procedure, the DSA contributed 94% of the 
total dose to eye lens followed by road mapping (4.7%), cine trace (0.5%) and 
fluoroscopy (0.8%). This information [Figure 6& Figure 7] is important in 
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post-procedure analysis for future dose minimization strategies and can be 
utilized for the interventionalists’ training.  
 
IV. Discussion 
Different techniques have been recommended to reduce radiation dose during 
IR procedures, such as using pulsed mode fluoroscopy exposure, shortening 
the exposure time, increasing distance between x-ray source and patient, 
reducing distance between image receptor and patient, minimizing the 
magnification, maximizing collimation, using last image hold technique, 
changing C-arm angles and using low frame rate exposure[23, 24].  
Applying these strategies and using a direct dosimetry system can significantly 
improve patient radiation safety during IR procedures. Direct dose 
measurement is not feasible for all IR procedures; for this reason, the dose 
metric parameters (FT, KAP, AKIRP) are regularly monitored and recorded. To 
prevent skin injuries, a certain threshold level has been suggested for each 
parameter, for instance FT 40-60 min, KAP 500 Gy.cm
2
, IRP 5 Gy and peak 
skin dose 3 Gy [25]. While these parameters are mostly recorded after each IR 
procedure as a rough estimate of the radiation dose received by patients, some 
studies have shown that they do not provide sufficient information during a 
procedure to control local skin dose to a given patient [5, 6, 26, 27]. The actual 
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patient’s entrance skin dose can be calculated from exposure air kerma at 
reference point by incorporating table attenuation, backscatter factor, 
correction of actual source skin distance (Inverse square law) of reference 
point to actual skin point and correction of mass energy absorption coefficients 
of skin to air [28]. Recently, automatic skin dose simulation tools were used to 
estimate the entrance skin dose from the geometrical and exposure information 
extracted from DICOM tags and system parameters. These software are able to 
map the estimated skin dose distribution on standard and anatomical patient 
model phantoms [28, 29]. 
In this study, KAP values showed strong correlation with doses received at LE 
and LOC regions.  For the cerebral angiography procedure, the patient’s eyes 
are frequently exposed to primary radiation beams. This may be the main 
reason that this strong correlation was observed between KAP and measured 
dose at LE and LOC regions. In our center, the lateral tube was always placed 
at the left side of the patient’s head, therefore AKL and measured doses at LE 
and LOC showed strong correlation, unlike the frontal tube, which showed a 
weak correlation with the measured doses.  
 For all cases measured dose at LOC was higher than LE. This difference can 
be explained by two reasons: first, the closer proximity of the LOC detector to 
the lateral x-ray tube compared to the LE detector; and second, collimation of 
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the radiation field.  The radiography team was well trained to minimize the 
irradiation dose to the left eye lens by collimating the radiation field of the 
lateral tube. With proper collimation of the radiation field, the detector on the 
eyelid would be out of direct radiation from the lateral tube, while the detector 
on the outer canthus would still be within the direct beam. The collimation 
effect would be significant for embolization procedures at the posterior region 
of the skull, which can completely place the patient’s eyes outside of the 
primary beam. This finding clearly shows the importance of choosing the right 
location for the point dose measurement during a non-homogenous dose 
distribution procedure. The maximum eye lens dose of 1492 mGy was 
measured at LOC region for an AVM case, followed by 907 mGy for an 
aneurysm case and 665 mGy for a diagnostic angiography procedure.  
This study showed that among the 35 patients, LOC regions of 8 patients and 
LE region of 1 patient were found to receive higher doses than the assumed 
threshold dose for cataract formation (500 mGy). Recent studies have reported 
the average and maximum patient eye doses for neuro-interventional radiology 
procedures [Table 2]. Generally, therapeutic procedures are more complicated 
than diagnostic procedures, which lead to longer exposure time and higher 
dose delivery to patients’ bodies (KAP). The results of our study are in good 
agreement with previous studies. As shown, the detectors positioned at the 
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lateral margin received higher doses in comparison to those placed on the 
eyelids or inferior and superior margins (I-S margins).  
As a high frame rate and high quality imaging technique, DSA plays a major 
role in contributing to patient’s dose. Some studies have tried to evaluate the 
effect of DSA exposure on patient dose [30, 31]. The MOSkin detector enables 
us to study the contribution of various exposure parameters on patient’s dose 
during a clinical procedure. However, the main objective of the patient 
dosimetry is to monitor the total dose delivered to the patient’s body as well as 
the dose delivered to the sensitive organs. A real-time dose monitoring system 
can provide real-time information for each particular exposure. This 
information can be used to study the techniques to optimize patient's radiation 
safety during IR procedures, such as changing the exposure angulation, 
adjusting the exposure collimation, and shortening the exposure time when the 
dose at detector position reaches a critical level.  
In summary, indirect dose measurements using machine available dose metrics 
such as KAP, FT and air kerma are not accurate indicators of the actual dose 
received by patients undergoing interventional radiological procedures. This 
information can only be obtained via actual in-vivo dose measurements. In this 
work, we demonstrated the feasibility of using the MOSkin dose monitoring 
system as a real time, in-vivo dose measurement system. The system was 
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successfully used to measure patient eye lens dose during neuro-interventional 
procedures. This system enables interventionalists to have better awareness of 
the patient’s eye lens dose during clinical procedures. 
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List of figures: 
 
Figure 1 (a) MOSkin dosimetry system (b) MOSkin detector and (c) MOSkin detector 
components. 
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Figure 2 (a) MOSkin dosimetry system was placed at treatment room and accumulated 
dose values were displayed using the FETch software in front of the interventionalist and 
the radiographer during treatment procedures. (b) FETch display showing the 
accumulated dose values.  
 
Figure 3 (a) The MOSkin detectors were positioned on the left eyelid and left outer 
canthus regions during interventional procedures. (b) This detector is almost invisible on 
the displayed image. 
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Figure 4 The boxplot shows the median and distribution of the dose delivered to the 
outer canthus and eyelid areas for each treatment procedure for the 35 participating 
patients, comprising 19 diagnostic angiographies, 8 treatments of cerebral aneurysms, 
and 8 embolizations of AVMs. 
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Figure 5 Correlation between the measured dose to left outer canthus and left eyelid 
regions to (a) KAP, (b) FT, (c) AKL and (d) AKF. 
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Figure 6 The accumulated dose trend line at LOC for an AVM procedure. From the real-
time response pattern of the MOSkin detector, it is possible to investigate the dose 
delivered to the patients. The temporal dose pattern allows us to evaluate the contribution 
of each exposure to dose delivery to the patient’s eye. Two particular exposures were 
labeled in this graph, d1 is dose before exposure and d2 is the dose after exposure. The 
increment dose (∆d) indicates the absorbed 
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Figure 7 The dose delivered to the patient’s LOC depicted as contribution of different 
types of  exposure (e.g. fluoroscopy, road mapping, DSA and Cine Trace). 
List of Tables: 
Table 1 Exposure parameters and dose delivered to LE and LOC areas, averages, 
medians, and 95th percentiles. 
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Table 2 Comparison of published data on eye doses for neuro-interventional radiology 
procedure. 
 
 
 
 
 
